Juluca Is the Latest Once-Daily Combo Med for HIV

Juluca (jah-LOO-kah) will be a new two-drug combo for HIV.

It combines 50 mg of dolutegravir (Tivicay) and 25 mg of rilpivirine (Edurant) in a once-daily tablet.

Expect Juluca to be used for patients who've been on a stable regimen for at least six months...especially if they can't tolerate certain HIV meds or need fewer pills per day.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals